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ABSTRACT 
 
Backgorund: JKN program has stipulated the INA CBGs reimbursement for the payment of 
treatment in referral health facilities, including for chronic renal disease which is a disease burden. 
This study aimed to analyze factors influencing the difference between Indonesian case-based 
group reimbursement and medical cost for patients with chronic renal disease cases in Kasih Ibu 
Hospital, Surakarta. 
Subjects and Method: The study design was an analytic observational with cross sectional 
design. The study was conducted in Kasih Ibu Hospital Surakarta in August-October, 2017. With a 
total of 231 subjects sample which was selected by using proportional random sampling. The 
dependent variable was the difference between Indonesian case-based group reimbursement and 
medical cost. The independent variables were length of stay, type of class, medical treatment/ 
surgery, ICU treatment, and medication use. The data were analyzed using multiple linear 
regression. 
Result: INA CBGs reimbursement (mean= Rp 6,120,000; SD= Rp 2,330,000) paid by BPJS 
Kesehatan was lower than actual hospital’s medical care cost (mean= Rp 7,070,000; SD= Rp 
4,650,000). Factors profitable for hospitals were medical treatments/ surgery (b= 0.032; p= 
0.552). Factors that inflicted financial loss were class 1 care (b= -0.104; p= 0.094), class 2 care (b= 
-0.033; p= 0.590) compared to class 3 care, length of stay (b= -0.541; p<0.001), medication use in 
accordance with national formulation (b= -0.183; p= 0.008) and the use of ICU (b= -0.045; p= 
0.543). Patients who upgraded the class type (mean= Rp 5,526,074; SD= Rp 1,449,621) was higher 
than hospital’s medical cost for class 2 (mean= Rp 3,933,767; SD= Rp 1,887,900). 
Conclusion: Mean of INA CBGs reimbursement on inpatient care of chronic renal disease is 
lower than the mean of hospital’s medical care cost. Length of stay and doctors’ compliance in 
using national medication formulation are important determinants to increase medical care cost. 
Hospital obtains profit from patients who upgrade type of class.  
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BACKGROUND 
Chronic Renal Disease (CRD) is an import-
ant global health issue (KDOQI, 2002). In 
the last ten years the CRD cases are 
escalating in Indonesia (IRR, 2007). The 
soaring number of CRD cases and keep on 
increasing is a disease burden since the 
social economy impact faced by family, 
society, nation and healthcare system. The 
end-stage of CRD is called Chronic Renal 
Failure which needs help in filtering blood 
called as hemodialysis. The treatment for 
CRD patients related to the increasing 
medical care cost, 65-77% depends on the 
stage (Brown et al, 1999). The increasing 
prevalence of CRD new cases is followed by 
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the utilization of advanced health facilities 
and the amount of expense should be spent 
for medical care. The increasing cost of 
CRD treatment which is considerable for 
patients and health facilities, requires a 
systematic effort that is able to secure 
society also providers from unexpected 
financial burden. 
Hospitals as one of the advanced 
health facilities has calculated the medical 
care cost based on components namely unit 
cost, medical service, non-medical, deve-
lopment plan, and the expected profit. The 
cost is later used as the reimbursement of 
service cost implemented in the hospital. 
Based on the morbidity data of Kasih Ibu 
hospital in 2016 there was an increasing 
number of CRD inpatients care by 35% 
compared to 2015. The indications of CRD 
inpatient care truly vary, especially is 
caused by its complication such as anemia 
with Hb <7 g/dL, extreme shortness of 
breath because of cardiovascular complica-
tion or hypertension heart disease, hyper-
kalemia, dyspepsia from uremia that is 
caused by inadequate dialysis or the failure 
of low protein diet, repairing access for 
dialysis and making a new access since the 
old one is disappear or no longer feasible to 
use. The financing sources for inpatient 
care that are mostly used in Kasih Ibu 
hospital are BPJS Kesehatan with a total of 
53%, followed by out-of pocket payment 
3%, private-owned insurance 14%, coor-
dination of benefit (COB) with BPJS Kese-
hatan 1%. 
The addition of advanced health 
facilities which collaborate with BPJS 
especially private-owned hospitals in 
Central Java province and Surakarta in 
particular surely turns to competitor for the 
existing hospitals.   It is also indicating that 
hospitals are demanded to be more efficient 
and effective in organizing medical care to 
be able to survive in the competition era 
among hospitals in receiving JKN patients. 
Moreover it is realized that all citizens are 
obliged to be JKN members in the 
upcoming 2019 (UU No.11/2014). 
During 3 years of JKN implementa-
tion there are changes upon policies namely 
the amendment of  Health Minister’s Regu-
lation No.52/ 2014 to Health Minister’s 
Regulation No.64 /2016 on the subject of 
The Amendment on Health Minister’s 
Regulation  No.52 on the subject of Service 
Tariff Standard in the Organization of 
Health Insurance Program. The amend-
ment of Health Minister’s Regulation more 
or less generates uneasiness especiall for 
hospitals as the provider since there are 
several tariffs that are declining yet there 
are others that are increasing. Furthermore 
disagreement occurs between medical care 
cost and INA CBG’s reimbursement. 
Kompasiana.com stated that there are gaps  
between hospitals’ cost of care and CBG’s 
payment system that results in hospitals 
should endure financial risks (Rinawati, 
2015). In other side, Republika online news 
stated that unit cost in INA CBG’s does not 
cause financial loss to the hospitals (Riadi, 
2016). Hospitals that can compress pro-
duction cost of medical care for certain 
diagnosis groups hence the average cost 
(unit cost) per patient is lower than INA 
CBG’s reimbursement, may obtain profit 
from CRD patients care by means of 
hemodialysis. In contrast, if unit cost per 
patient of CRD is higher than INA CBG’s 
then hospitals will endure loss. 
Based on the background it was 
important to study whether there is dis-
crepancy or distinction between the average 
cost of CRD inpatient care undergone by 
hospital and the tariff of CRD inpatient care 
determined by BPJS Kesehatan. It was also 
important to study factors that influence 
the distinctions. 
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SUBJECTS AND METHOD 
The study was an analytic observational 
with cross sectional approach. The study 
was conducted in Kasih Ibu Hospital 
Surakarta which was a type B private-
owned non-teaching hospital. The study 
was conducted in August – October 2017. 
There were a total of 231 subjects with 
proportional random sampling technique. 
Data collection was conducted by using 
observation on patients’ medical record and 
costing data that has been verified by BPJS 
Kesehatan. INA CBGs’ codes used for 
chronic renal diseases including: N-4-10-I, 
N-4-10-II, N-4-10-III, N-4-16-I, N-4-16-II, 
N-4-16-III, N-1-12-I, N-1-12-II, N-1-12-III. 
Dependent variable was the difference of 
INA CBGs’ reimbursement with hospital’s 
medical care cost for inpatient care of 
chronic renal disease cases. Independent 
variables include type of class, length of 
stay, medical treatments/surgeries, medi-
cation use in accordance with national 
formulation and the use of ICU. Data 
analysis used multiple linear regressions. 
 
RESULT 
1. Characteristics of the Study 
Subjects 
The study result toward the characteristics 
frequency distribution of 200 study sub-
jects showed that there were more male 
than female subjects. Most subjects were 
above 35 years. It could be seen in Table 1. 
Characteristics frequency distribution of 31 
study subjects who upgraded from patients 
of class 3 to class 2 could be seen in Table 2.
Table 1. Characteristics of the study subjects based on age and sex categories 
Characteristics N % 
Sex Categories   
Male 105 52.5 
Female 95 47.5 
Age   
20 – 35 years 17 8.5 
≥35 years 183 91.5 
  
Table 2. Characteristics of study subjects for patients who upgraded the type of 
class from class 3 to class 2 for inpatient care of CRD cases 
Characteristics Category N % 
Sex categories Male 19 61.2 
 Female 12 38.7 
Age 20 – 35 years 3 9.68 
 ≥35 years 28 90.32 
 
Table 3. Description of Variables of the Study   
Variables n Mean SD Minimum Maximum 
INA CBGs reimbursement (x Rp 1,000,000) 200 6.12 2.33 3.31 12.47 
Hospital cost of care (x Rp1,000,000) 200 7.07 4.65 1.27 38.57 
Length of stay (day) 200 3.71 1.68 1 9 
Difference of tariff (x Rp 1,000,000) 200 -0.96 0.96 -2.61 5.08 
 
2. Univariate Analysis 
Description of univariate study on variables 
of the study explained the general descrip-
tion of each variable of the study that 
consisted of INA CBGs reimbursement, 
hospital’s medical care cost, difference of 
tariff on inpatient care of CRD cases in 
Journal of Health Policy and Management (2017), 2(2): 117-127 
https://doi.org/10.26911/thejhpm.2017.02.02.03 
 
120 e-ISSN: 2549-0281 (online) 
million rupiah unit, and length of stay in 
days. It can be seen in Table 3. 
Table 3 showed that mean of INA 
CBG’s reimbursement for inpatient care of 
Chronic Renal Disease cases was smaller 
than the mean of medical care cost at Kasih 
Ibu Hopsital with tariff difference was 
minus Rp 960,ooo. The length of stay 
ranged from 1 day at the minimum and 9 
days at the maximum, with the average 
length of stay was 4 days. 
Categorical data that included type of 
class, with or without medical treatment/ 
surgery, the use of ICU and the use of 
medicine in accordance with JKN national 
formulation was presented in Table 4. 
3. Bivariate Analysis 
Bivariate analysis explains about the asso-
ciation of one variable with another varia-
ble. The variables presented were the diffe-
rence between INA CBGs’ reimbursement 
and hospital’s medical care cost also 
doctors’ compliance in using medicine in 
accordance with JKN National Formu-
lation. It can be seen in Picture 1 and 2. 
Table 4. Description of Variables of the Study 
Variables Category n % 
Type of Class 
 
Class 1 
Class 2 
Class 3 
80 
56 
64 
40 
28 
32 
Level of Severity 
 
Mild 
Moderate 
Severe 
64 
115 
21 
32 
57.5 
10.5 
Medical treatment/ Surgery 
 
Yes 
No 
176 
24 
88 
12 
Use of ICU 
 
Yes 
No 
29 
171 
14.5 
85.5 
The Use of Medicine in accordance 
with National Formulation 
Yes 
No 
178 
21 
89.4 
10.6 
 
Picture 1. Scatter plot histogram on the association between 
length of stay and BPJS reimbursement difference  
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Picture 2. Box plot histogram on the association of the use 
of national formulation and BPJS reimbursement difference 
 
Picture 1 explained that there was a 
negative association between length of stay 
with the difference of INA CBGs’ reim-
bursement and hospital’s care cost. Picture 
2 explain that there was a negative asso-
ciation between doctors’ compliance in 
using medicine in accordance with national 
formulation with the difference of INA 
CBGs’ reimbursement and hospital’s care 
cost. 
4. Multivariate Analysis 
Multivariate analysis explains the associa-
tion of more than one independent varia-
bles. The analyzed variables include type of 
class, length of stay (LOS), medical treat-
ments/surgery, the use of ICU and the use 
of medicine in accordance with JKN 
National Formulation. 
Table 5 showed that there was a 
negative association between the difference 
of INA CBGs’ reimbursement and medical 
care cost of CRD case inpatient care with 
length of stay which was statistically 
significant. Each 1 day addition of length of 
stay would cause a financial loss for 
hospital as much as Rp. 1,187,602 (b= -
0.542; CI 95%= -1,436,148 to -939,055; 
p<0.001).  
There was negative association 
between the difference of tariff with 
doctors’ incompliance in using medicine in 
accordance with JKN National Formulation 
(b= -0.183; 95% CI= -3,844,102 to 579,120 
p= 0.008). Doctors’ incompliance in using 
medicine in accordance with National 
Formulation might cause a financial loss for 
hospital as much as Rp 2,220,789. 
There was a positive association 
between tariff difference with medical 
treatment/ surgery (b= 0.032; 95% CI = -
847,876 to 1,581,720; p= 0.552) however it 
was statistically insignificant. Also with the 
use of ICU (b= -0.045; 95% CI = -1,994,371 
to 1,053,382; p= 0.543). Class 1 care gene-
rated financial loss of Rp 783,260 com-
pared to class 3 (b= -0.104; 95% CI = -1.70 
to 0.13; p= 0.094).  
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Table 5. Result of multiple linear regression analysis on the association between 
the difference of INA CBGs’ reimbursement with medical care cost of CRD cases 
inpatient care and the factors that influence 
Independent Variables b 
95% CI  
p 
Lower Limit Upper Limit 
Constanta 663422 1739775    3066619 0.587 
Class 2 -267983 -1246942 710976 0.590 
Class 1 -783260 -1701513 134993 0.094 
Length of stay (days) -1187602 -1436148 -939055 0.000 
With medical treatment/surgery 366922 -847876 1581720 0.552 
ICU use -470494 -1994371 1053382 0.543 
Medicine administration not fit national 
formulation 
-2211611 -3844102 579120 0.008 
Patients’ age (years) 10990 -21434 43415 0.505 
Complication -1720828 -2820160 -621496 0.002 
Sex categories 259362 -492168 1010894 0.497 
Level of severity 1643003 940418 2345588 0.000 
n observation = 200 
Adjusted R2  = 50.4% 
p < 0.001 
    
 
There was negative association 
between class 2 care (b= -0.03; CI 95%= -
1,246,942 to 710,976; p= 0.590) with tariff 
difference however it was statistically 
insignificant. There was positive association 
between tariff difference with level of 
severity and statistically significant (b= 
0.27; 95% CI = 940,418 to 2,345,588; p< 
0.001). 
Study subjects who upgraded the type 
of class showed that the mean of INA CBGs’ 
tariff of inpatient care of CRD cases for 
class 2 patients were higher than medical 
care cost of class 2 at Kasih Ibu hospital, 
Surakarta. It was explained in Table 6.
Table 6. Description of variable of the study for patients who upgraded the type of 
class from class 3 to class 2 of inpatient care of CRD cases 
Variables N Mean SD Minimum Maximum 
BPJS reimbursement for class 2 
(rupiah) 
31 5,526,074 1,449,621 3,976,600 8,686,600 
BPJS reimbursement for class 3 31 4,619,135 1,199,608 3,313,800 7,238,900 
Hospital’s care cost for class 2 31 3,933,767 1,887,900 1,345,207 1,345,207 
Difference between hospital’s Care Cost 
for class 2 and BPJS reimbursement for 
class 3 
31 685,358 1,19,.608 -3,372,901 4,732,493 
Difference between BPJS reimburse-
ment for class 2 and class 3 
31 906,938 264,171 303,000 1,447,700 
 
DISCUSSION 
1. INA CBGs’ reimbursement for 
inpatient care of CRD compared to 
medical care cost in Kasih Ibu 
Hospital, Surakarta 
The analysis result found that INA CBGs’ 
reimbursement for inpatient care of CDR 
cases according to the type of class was 
lower than medical care cost in Kasih Ibu 
Hospital Surakarta. The result of the study 
is in line with a study by Hudayani (2016) 
that showed there is distinction between 
INA CBGs’ reimbursement and hospital’s 
real cost in hemorrhagic stroke. In which 
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the total of INA CBGs’ reimbursement is 
lower than hospital’s real cost. 
Calculating the tariff and the cost of 
medical care in healthcare facilities such as 
private-owned hospitals is an important 
aspect in the era of prospective payment of 
current JKN program. Medical care cost 
spent by the hospital to provide treatment 
for patients is truly varied. The variation is 
influenced by number of resources used in 
particular for inpatient care activities as 
well as the value or price determined by the 
hospital for various service given (Sloan, 
2002). Payment with INA CBGs system 
implies that hospital with the team of 
doctors should set fix cost and variable cost 
of what must be spent by the hospital for 
the third party (Thabrany, 2014). The 
determination is made based on clinical 
pathways. Therefore, it is important for the 
hospital to have and make standard proce-
dure in disease management with clinical 
pathway particularly for CRD cases. So that 
hospital can perform quality control and 
cost control in providing optimal, effective 
and efficient care.  
2. Advantage and disadvantage en-
dured by hospital related to claim 
for INA CBGs reimbursement 
The analysis result found that INA CBGs’ 
reimbursement was lower than hospital’s 
medical care cost for inpatient care of CDR 
case according to the type of class, hence 
hospital endured financial loss. The pre-
vious study found that INA CBGs’ reim-
bursement was higher than hospital’s tariff 
regardless the diagnosis/ case of disease 
(Rahayuningrum, 2016). 
Payment of INA CBGs claim gives 
advantages in facilitating the revenue 
calculation for hospital. The difference of 
advantages and disadvantages of INA 
CBGs’ reimbursement implementation in 
private-owned hospitals is generated by the 
various amount of medical care bill for each 
hospital. The amount of bill agreed in INA 
CBGs reimbursement for a certain diag-
nosis and procedure should be agreed by all 
hospitals in certain region through hospital 
organization which is the local Indonesia 
Hospital Association (PERSI), therefore 
PERSI should improve its role in this 
mater. In addition, one of the factors 
considered in hospital’s annual operational 
budget planning is the amount of profit 
possibly obtained to subsequently develop 
hospital.   
Tamtomo (1995) explained that 
hospital should be able to maintain its 
sustainability through surplus or profit 
without neglecting the social functions. 
Furthermore, as an effort to consistently 
have competitive profit compare to other 
healthcare providers, hospital should 
improve cost-effectiveness and cost-effecti-
veness without reducing service quality, 
having data and information flow which 
help in optimizing resources and creating 
new options in the service quality improve-
ment (Hidayat, 2016). 
3. Association between type of class 
with tariff difference 
The result of analysis showed that medical 
care in class 1 and class 2 had negative 
association and statistically come close to 
significant compared to medical care in 
class 3with a growing difference between 
the tariff and hospital’s medical care cost. 
INA CBG’s reimbursement has stipu-
lated class-based tariff that includes class 1, 
class 2, and class 3. In line with Appendix 
of Health Minister’s Regulation No. 64/ 
2016 on the subject of the Amendment on 
Health Minister’s Regulation No. 52/2014 
on the subject of Healthcare Tariff 
Standard in the Administration of Health 
Insurance Program, hence there is tariff 
difference in each type of class. The higher 
the type of class is, the bigger amount of 
INA CBGs’ in rupiah will be. It is in line 
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with the tariff of inpatient room at hospital, 
the higher the type of class is, the more 
expensive the tariff of inpatient care room 
will be. The difference of inpatient room 
tariff is determined by the facilities, 
convenience, as well as privacy provided by 
the hospital. However, the provided care, 
medication, as well as service related to 
disease management by doctors, nurses, 
and other health workers are not different. 
4. Association between length of stay 
with tariff difference 
The result of analysis showed that there 
was negative relationship and statistically 
significant between length of stay at 
hospital for CDR cases and the tariff 
difference of INA CBGs and hospital 
medical care cost. Aggarwal et al. (2014) 
explained that the increasing length of stay 
of inpatient care for CDR cases will increase 
inpatient medical care cost spent with the 
mean of LOS for CRD cases is 5 up to 6 
days. 
The length of stay for various 
diagnosis is varied and one of the indicators 
for medical care at the hospital which is 
regularly measured for calculating level of 
utilization and financial report for policy 
making in management and directors level. 
The ideal length of stay according to Health 
Department in 2015 was 3 – 12 days. In the 
study the mean of length of stay for CRD 
cases was 4 days. Therefore, from economy 
aspect, the longer the LOS is means the 
higher the cost should be spent by the 
hospital since INA CBGs’ reimbursement is 
permanent in nature. From the medical 
aspect, the longer the LOS is may show 
insufficient medical quality since patients 
should be treated longer or it takes a long 
time to recover. Whether the LOS value is 
ideal for certain disease diagnosis can be 
observed if the hospital has implemented 
and possessed Clinical Pathway for every 
disease diagnosis. 
5. Association between medical treat-
ment/ surgery tariff difference 
The analysis result showed that there was 
positive association which was insignificant 
between medical treatment/surgery with 
the tariff difference of INA CBGs’ and 
medical care cost of inpatient care for CRD 
cases at the hospital. In accordance with 
Health Minister’s Regulation No.76/2016 
on the subject of INA CBGs’ guidelines in 
JKN implementation there difference in the 
structure of case-group code between 
procedural inpatient and non procedural 
inpatient. Procedural inpatient includes 
inpatient with surgery such as the making 
or installation of vascular access for hemo-
dialysis patients by cardiothoracic surgeon, 
whereas non-procedural inpatient includes 
care with non-surgery medical treatments 
such as hemodialysis and blood trans-
fusion. Thus INA CBGs’ reimbursement has 
accommodated the increasing medical care 
cost which is higher for procedural 
inpatient care than non-procedural 
inpatient care. 
6. Association between ICU utiliza-
tion with tariff difference 
The analysis result showed that there was 
negative association which was insignifi-
cant between the use of inpatient care in 
ICU with tariff difference of INA CBGs’ and 
medical care cost for CRD cases at the 
hospital. It different from the previous 
study that showed that there was a 
significant association between ICU care 
with hospital’s tariff (Rahayuningrum, 
2016). Karabatsou et al. (2016) explained 
that the total cost of ICU care is greatly 
influenced by  3 things namely the length of 
stay in ICU, disease severity, the need for 
mechanic ventilator and the use of 
continous dialysisatau CRRT (Continous 
Renal Replacement Therapy). Hence it 
explains that the difference of study results 
may be inflicted by the difference of 
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diagnosis, disease severity, and the absence 
of CRRT facilities at the hospital. Therefore, 
dialysis is generally performed with 4-4.5 
hours method in ICU or in Hemodialysis 
Unit without consuming longer time. 
7. Association between use of medi-
cine in accordance with JKN 
national formulation with tariff 
difference 
The analysis result showed that there was a 
negative association which was significant 
between compliance in using medicine by 
National Formulation with tariff difference 
between INA CBGs’ and hospital’s medical 
care cost. It means that the more doctors 
who do not use medicines in accordance 
with National Formulation the greater the 
loss endured by the hospital. 
Based on the Republic of Indonesia 
Health Minister’s Decree No.328/2013 the 
most of the medicines categorized into 
National Formulation are generic medi-
cines. However in reality it is difficult 
especially for private-owned hospitals to 
obtain the medicines in compliance with 
National Formulation by means of e-
purchasing as it is explained in Health 
Minister’s Regulation No.28/2014 on the 
subject of medicines procurement for JKN 
patients care. The problem is still becoming 
an hindrance up to now after JKN has 
proceeded for more than 3 years. Hence the 
hospitals generally will conduct their own 
medicine procurement independently by 
seeking for generic medicines with prices 
come close to the JKN national formulation 
prices. A study by Kalo et al. (2014) 
explains that generic medicines use will 
increase patients’ accessibility to obtain 
therapy in addition to suppress and cut 
down the expenses of pharmacy or medi-
cines cost. The similar thing is also being 
followed by the policy on JKN National 
Formulation usage in Indonesia with one of 
the purpose is to control public healthcare 
cost. Factors that influence the policy 
consist of patients, doctors, pharmacists, 
and the manager of formulation makers 
(Howard et al., 2017). Furthermore, it is 
explained in the above study that Medical 
Specialists are likely to prescribe more for 
patent medicines. 
It is in accordance with the result of 
the current study that there were still study 
subjects who did not obtain medicines in 
compliance with National Formulation 
(generic medicine) they get the patent 
medicine instead. The reason is because 
there are doctors and pharmacists who 
perceive that generic medicines are not as 
good as the original or patent medicines 
(Dunne, 2014). For that it takes education 
and more studies on generic medicine’s 
effectiveness for the value-based medicine 
thus it can increase the compliance and will 
of health practitioners especially Medical 
Specialists to prescribe generic medicines. 
8. Association between amount of 
cost for patients who upgrade the 
type of class at hospital with tariff 
difference 
The analysis result showed that the mean of 
INA CBGs’ reimbursement of inpatient care 
for CRD cases in class 2 was higher than the 
mean of patients’ medical care cost of class 
2 in Kasih Ibu Hospital Surakarta. It means 
the hospital obtain profit from patients who 
upgrade from class 3 to class 2 of inpatient 
care for CRD cases. The amount of cost 
sharing for patients who upgrade the type 
of class is regulated in Health Minister’s 
Regulation No.64/2016. For patients who 
upgrade the type of class from class 3 to 
class 2, the patients should pay the tariff 
difference of INA CBGs for the class they 
occupy, deducted by the tariff of INA CBGs’ 
of class they deserve to be in. 
The limitation of the study among 
others are that the study was conducted 
without considering other factors of the 
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cost component, that probably may 
influence the medical care cost such as the 
medical fee of medical workers (doctors 
and nurses) and the study was conducted 
without concerning the patients’ satisfact-
ion level toward the care performed in 
Kasih Ibu Hospital, Surakarta. 
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